Subcutaneous Route and Pharmacology of Metoclopramide
Status:
Completed
Trial end date:
2019-02-08
Target enrollment:
Participant gender:
Summary
Subcutaneous (SC) route has become a standard of care of many drugs administration in
palliative medicine. A preliminary study showed that, although it was widely adopted among
palliative care practitioners for routinely prescribed medications, standards of proof are
still lacking for many molecules. Among them, metoclopramide is a largely employed drug for
nausea and vomiting treatment, particularly in palliative care and oncology. Therefore, the
investigator aim to study absorption and efficacy of subcutaneous administration of
metoclopramide.